Juvenescence Investor

Juvenescence Limited is a British Virgin Islands-based holding company that invests in human ageing and longevity. Juvenescence has raised USD $65M to build an ecosystem and pipeline of assets targeting ageing, age-related disease and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in their already ageing world will have profound implications on all sectors of society, and in particular healthcare, education, insurance and leisure.
Technology: Drug Design
Industry: Regenerative Medicine
Headquarters: Douglas, Isle of Man
Founded Date: 2016
Employees Number: undisclosed
Funding Status: undisclosed
Investor Type: undisclosed
Investment Stage: Undisclosed
Number Of Exits: 1

Visit Website
Register and Claim Ownership